Skip to content
Recall Observatory FDA recall evidence

Drug product

Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle, Rx only, Distributed by Mylan Pharmaceuticals Inc. Morgantown, WV 26505, NDC 0378-1819-01

D-1084-2014

January 14, 2014

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 67399
Status
Terminated
Classification
Class II
Quantity
138,970 bottles
Official record key
drug-enforcement:D-1084-2014

Official wording

Reason: Subpotent Drug: Assay results obtained during stability testing for Levothyroxine Sodium Tablets, USP were below specification.

Code information: Lot 3037531 EXP 03/14 Lot 3038284 EXP 04/14

Distribution pattern: Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent